161 related articles for article (PubMed ID: 33220286)
1. Administration of a VIP-antagonist in vivo modifies ovarian hormone secretion in a rat model with polycystic ovary syndrome.
Morales-Ledesma L; Trujillo Hernández A; Ramírez MI; Rosas G; Linares R
Life Sci; 2021 Jan; 265():118792. PubMed ID: 33220286
[TBL] [Abstract][Full Text] [Related]
2. Participation of vasoactive intestinal polypeptide in ovarian steroids production during the rat estrous cycle and in the development of estradiol valerate-induced polycystic ovary.
Parra C; Fiedler JL; Luna SL; Greiner M; Padmanabhan V; Lara HE
Reproduction; 2007 Jan; 133(1):147-54. PubMed ID: 17244741
[TBL] [Abstract][Full Text] [Related]
3. In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian β-adrenoreceptors improve ovulation.
Venegas B; De León Gordillo LY; Rosas G; Espinoza JA; Morán C; Domínguez R; Morales-Ledesma L
Reprod Biol Endocrinol; 2019 Nov; 17(1):95. PubMed ID: 31744506
[TBL] [Abstract][Full Text] [Related]
4. Amitriptyline plays important roles in modifying the ovarian morphology and improving its functions in rats with estradiol valerate-induced polycystic ovary.
Li X; Wang S; Zhang L; Zhang L; Liu J; Luo H; Gou K; Cui S
Arch Pharm Res; 2019 Apr; 42(4):344-358. PubMed ID: 28887616
[TBL] [Abstract][Full Text] [Related]
5. The Neural Signals of the Superior Ovarian Nerve Modulate in an Asymmetric Way the Ovarian Steroidogenic Response to the Vasoactive Intestinal Peptide.
Rosas G; Linares R; Ramírez DA; Vieyra E; Trujillo A; Domínguez R; Morales-Ledesma L
Front Physiol; 2018; 9():1142. PubMed ID: 30177887
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric steroidogenic response by the ovaries to the vasoactive intestinal peptide.
Rosas G; Ramírez MI; Linares R; Trujillo A; Domínguez R; Morales-Ledesma L
Endocrine; 2015 Apr; 48(3):968-77. PubMed ID: 25331816
[TBL] [Abstract][Full Text] [Related]
7. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation.
Barria A; Leyton V; Ojeda SR; Lara HE
Endocrinology; 1993 Dec; 133(6):2696-703. PubMed ID: 8243293
[TBL] [Abstract][Full Text] [Related]
8. Increased Vasoactive Intestinal Peptide (VIP) in polycystic ovary syndrome patients undergoing IVF.
Sallicandro L; Gliozheni E; Feudi D; Sabbatini P; Pellegrino RM; Alabed HBR; Baldini D; Gerli S; Alviggi C; Cascardi E; Cicinelli E; Malvasi A; Fioretti B
Front Endocrinol (Lausanne); 2024; 15():1331282. PubMed ID: 38774232
[TBL] [Abstract][Full Text] [Related]
9. Neurotransmitter alteration in a testosterone propionate-induced polycystic ovarian syndrome rat model.
Chaudhari NK; Nampoothiri LP
Horm Mol Biol Clin Investig; 2017 Feb; 29(2):71-77. PubMed ID: 27802175
[TBL] [Abstract][Full Text] [Related]
10. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
11. Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress.
Huang Y; Zhang X
Am J Physiol Endocrinol Metab; 2021 Jun; 320(6):E1085-E1092. PubMed ID: 33900851
[TBL] [Abstract][Full Text] [Related]
12. Activation of ovarian sympathetic nerves in polycystic ovary syndrome.
Lara HE; Ferruz JL; Luza S; Bustamante DA; Borges Y; Ojeda SR
Endocrinology; 1993 Dec; 133(6):2690-5. PubMed ID: 7902268
[TBL] [Abstract][Full Text] [Related]
13. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
14. The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome.
Hong Y; Yin Y; Tan Y; Hong K; Zhou H
Med Sci Monit; 2019 Jan; 25():395-401. PubMed ID: 30636259
[TBL] [Abstract][Full Text] [Related]
15. An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat.
Lara HE; Dissen GA; Leyton V; Paredes A; Fuenzalida H; Fiedler JL; Ojeda SR
Endocrinology; 2000 Mar; 141(3):1059-72. PubMed ID: 10698182
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
Juarranz MG; De Neef P; Robberecht P
Prostate; 1999 Sep; 41(1):1-6. PubMed ID: 10440869
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D3 regulates steroidogenesis in granulosa cells through AMP-activated protein kinase (AMPK) activation in a mouse model of polycystic ovary syndrome.
Bakhshalizadeh S; Amidi F; Shirazi R; Shabani Nashtaei M
Cell Biochem Funct; 2018 Jun; 36(4):183-193. PubMed ID: 29676471
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of isoflavone-aglycone fraction from soybean (
Alivandi Farkhad S; Khazali H
Gynecol Endocrinol; 2019 Dec; 35(12):1078-1083. PubMed ID: 31185755
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effects of R10 fraction of garlic (Allium sativum L.) on hormonal levels, T cell polarization, and fertility-related genes in mice model of polycystic ovarian syndrome.
Falahatian S; Haddad R; Pakravan N
J Ovarian Res; 2022 Jan; 15(1):4. PubMed ID: 34991678
[TBL] [Abstract][Full Text] [Related]
20. Alterations of polyunsaturated fatty acid metabolism in ovarian tissues of polycystic ovary syndrome rats.
Huang R; Xue X; Li S; Wang Y; Sun Y; Liu W; Yin H; Tao T
J Cell Mol Med; 2018 Jul; 22(7):3388-3396. PubMed ID: 29602230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
